KPF
EGRX

K2 Principal Fund’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

K2 Principal Fund’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,496
Closed -$640K – 238
2016
Q2 		$640K Sell
16,496
-5,504
-25% -$214K 0.08% 100
2016
Q1 		$891K Buy
+22,000
New +$891K 0.12% 73
2015
Q4 		– Hold
0
– – – 178